Summary Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company provides products for the treatment of osteoarthritis of the knee and diabetic macular edema. Its products include low molecular weight fraction of human serum albumin and ultra-low dose of danazol. Ampio’s ultra-low dose of danazol is used for the oral treatment of diabetic macular edema. The ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.